BRS2-FM1-PM2 - Betaine/BHMT Remethylation
(Secondary Homocysteine clearance route for Methionine and SAMe Support)
1. Mission & Overview
Mission
Provide a parallel homocysteine clearance route so methionine and SAMe supply remain resilient when folate demand is high.
Overview
Provides an alternative route for converting homocysteine back to methionine via betaine-dependent remethylation through the BHMT enzyme (betaine–homocysteine methyltransferase), running independently of the folate cycle. This backup pathway keeps methionine and SAMe supply resilient when folate-dependent remethylation is constrained or under heavy demand. Betaine- and choline-rich dietary patterns support this route, helping maintain methylation capacity under variable one-carbon load.
- Offers a folate-independent route for homocysteine clearance via BHMT.
- Keeps methionine and SAMe supply resilient under high folate demand.
- Draws on betaine- and choline-rich dietary patterns.
2. Primary Biological Effects
↑ alternative homocysteine clearance; ↑ methionine regeneration; ↑ SAMe support; ↑ methylation resilience
3. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework. Biology → Phenome Confidence reflects how directly this mechanism's biology would be expected to affect the phenome within BRAIN architecture — not dietary treatment efficacy. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Low–Medium
- Rationale: Dietary patterns rich in folate, fibre, and methyl-donor nutrients associated with reduced ADHD symptoms intersect betaine/choline remethylation routes; choline implicated across neurodevelopmental disorders including ADHD. BHMT-mediated homocysteine clearance is established biochemistry — ADHD attention-outcome evidence for betaine supplementation specifically remains sparse (biology > evidence gap).
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low
- Rationale: Betaine lowers homocysteine acutely and choline supports parallel remethylation and downstream membrane chemistry — an indirect framework translation to cognitive clarity through methyl-donor sufficiency rather than measured cognitive outcomes in ADHD cohorts.
- Key References:
- Evidence Confidence: Low
4. Levers
Intervention Profile
Intervention Dominance: Diet-Dominant
- Betaine ← beetroot, spinach
- Choline ← eggs, soy lecithin
- zinc
-
Folate ← leafy greens, legumes, liver
-
Choline ← eggs, liver, salmon
-
Betaine (TMG) ← beetroot, spinach, quinoa
-
Vitamin B12 ← shellfish, sardines, eggs
1. Food Preparation & Delivery ONLY
- Consistent daily meal timing may support one-carbon and methyl-donor availability across the day.
- Soak and cook thoroughly to reduce phytates and improve mineral bioavailability; soaking and spro… — see Lentils — Preparation.
- Pair fat-soluble compounds with dietary fat to support absorption — see Spinach — Synergies.
- Sleep and stress context may indirectly affect methylation demand; lifestyle factors are secondary to dietary substrate supply for this PM.
5. Mechanistic Basis
Summary
BRS2-FM1-PM2 provides an alternative route for recycling homocysteine to methionine using betaine as a methyl donor. This pathway operates independently of the folate-dependent remethylation cycle (BRS2-FM1-PM1) and helps maintain methyl-donor availability when methylation demand is increased or folate-cycle efficiency is reduced.
(Betaine as a methyl donor)
Betaine (trimethylglycine) donates a methyl group to homocysteine through the enzyme betaine-homocysteine methyltransferase (BHMT), regenerating methionine and supporting continued participation in one-carbon metabolism.
(Parallel remethylation capacity)
Unlike folate/B12-dependent remethylation, the BHMT pathway provides an alternative route for homocysteine recycling. This contributes to methylation resilience by reducing reliance on a single remethylation pathway.
(Interaction with methyl-donor economy)
By supporting methionine regeneration, BHMT activity contributes indirectly to SAMe production (BRS2-FM1-PM3) and wider methyl-donor availability across methylation-dependent biological processes. Dietary choline can be oxidised to betaine, linking choline-rich foods to BHMT substrate availability → [Derbyshire and Maes, 2023]
(Boundaries of the mechanism)
This PM governs betaine-dependent homocysteine remethylation via BHMT only.
The folate/B12-dependent remethylation route belongs to BRS2-FM1-PM1. Methionine→SAMe conversion belongs to BRS2-FM1-PM3. Integrated cycle throughput belongs to BRS2-FM1-PM4.
Direct CDP-choline Kennedy-pathway phosphatidylcholine synthesis and SAMe-dependent PEMT methylation belong to BRS2-FM3-PM7. Acetylcholine synthesis from choline belongs to BRS1-FM2-PM5.
(Integration within BRS2)
This PM provides parallel remethylation capacity within BRS2(FM1) — Methylation Cycle Efficiency, reducing sole dependence on folate-cycle efficiency when methylation demand is high or folate-pathway function is constrained. It draws on BRS2(KC1) — One-Carbon Donor Pool for betaine and choline-derived methyl-donor availability.
5.1 Evidence Highlights
Introduction/Summary
The BHMT pathway is well characterised biochemically. The studies below highlight why a parallel remethylation route matters in practice — particularly when homocysteine lowering depends on nutrient combinations and when choline/betaine intake supports methylation resilience.
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Low-dose betaine supplementation produced immediate and sustained lowering of plasma homocysteine in healthy adults, supporting betaine as a dietary methyl-donor lever for homocysteine modulation → [Olthof et al., 2003]
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: In a randomised trial, vitamin B-12 alone lowered homocysteine by 22%, fish oil by 19%, and combined B-12 + fish oil by 39% — illustrating that remethylation support interacts with connected nutrient pathways beyond a single methyl-donor route → [Tao Huang et al., 2015] For BHMT, the parallel implication is that homocysteine clearance is best read across multiple remethylation and connected pathways rather than through betaine alone.
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Choline supports betaine availability through oxidation pathways and intersects broader methylation–membrane biology relevant to neurodevelopmental contexts including ADHD → [Derbyshire and Maes, 2023] This supports choline-rich dietary patterns as indirect BHMT support rather than isolated betaine supplementation as the only lever.
- Key References:
6. BRS Pathways and Connections
6.1 BRS Pathways
- None listed
6.2 Cross-BRS Mechanism Relationships
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS1-FM2-PM5 — Acetylcholine Synthesis Support — SAMe-dependent PEMT methylation
- BRS1-FM3-PM6 — Neuronal Membrane DHA Incorporation — Homocysteine disposal through transsulfuration toward cysteine
6.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
- BRS2-FM1-PM1 - Folate/B12-Dependent Homocysteine Remethylation
- BRS2-FM1-PM3 - SAMe Synthesis
- BRS2-FM1-PM4 - Methionine Cycle Flux
7. Scoreable Inputs & Modulation Signals
| Input Category | Example Inputs | PM relevance |
|---|---|---|
| Functional Property Potentials | methyl_donor_pattern; sulfur_amino_acid_context; choline_rich_food_matrix | May support betaine/bhmt remethylation. |
| Realised Functional States | consistent_daily_methyl_donor_coverage | May reflect meal-level pathway support. |
| Preparation Transformations | minimally_processed; whole_food_matrix | May preserve nutrient density for pathway support. |
8. References
- Tao Huang et al. (2015) — A Randomized Controlled Trial
- Olthof et al. (2003) — Low Dose Betaine Supplementation Leads to Immediate and Long Term Lowering of Plasma Homocysteine
- Derbyshire and Maes (2023) — Role of Choline in Neurodevelopmental Disorders
- Millichap and Yee (2012) — Diet Factor in Attention-Deficit/Hyperactivity Disorder